Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors
申请人:OMEROS CORPORATION
公开号:US20130267502A1
公开(公告)日:2013-10-10
This disclosure is directed to treatment of addictions and primary impulse-control disorders using phosphodiesterase 7 (PDE7) inhibitors, alone or in combination with other therapeutic agents.